Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay

Journal of Veterinary Diagnostic Investigation

Volumn 18, Issue 4, 2006, Pages 362-368

  Panarese, Serena ^a   Brunetti, Barbara ^a   Sarli, Giuseppe ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Department of Veterinary Public Health and Animal Pathology   (Italy)

Author keywords

Dog; Immunohistochemistry; Mammary gland; Telomerase; TRAP ELISA; Tumor

Indexed keywords

CANIS FAMILIARIS;

EID: 33746798892     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870601800407     Document Type: Article

References (53)

1. Argyle DJ, Nasir L: 2003, Telomerase: a potential diagnostic and therapeutic tool in canine oncology. Vet Pathol 40:1-7.
2. Bachor C, Bachor OA, Boukamp P: 1999, Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol 125:453-460.
3. Bednarek AK, Sahin A, Brenner AJ, et al.: 1997, Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res 3:11-16.
4. Biller BJ, Kitchell BE, Casey DC: 1998, Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. Am J Vet Res 59:1526-1529.
5. Blackburn EH: 1984, The molecular structure of centromeres and telomeres. Ann Rev Biochem 53:163-194.
6. Blackburn EH: 1990, Telomeres and their synthesis. Science 249:489-490.
7. Blackburn EH: 1991, Structure and function of telomeres. Nature 350:569-573.
8. Bodnar AG, Ouellette M, Frolkis M, et al.: 1998, Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
9. Boldizsar H, Szenci O, Muray T, Csenki J: 1992, Studies on canine mammary tumours. I. Age, seasonal and breed distribution. Acta Vet Hung 40:75-87.
10. Broccoli D, Young JW, De Lange T: 1995, Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci 92:9082-9086.
11. Burger AM, Bibby MC, Double JA: 1997, Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br J Cancer 75:516-522.
12. Campisi J, Kim S, Lim C, Rubio M: 2001, Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 36:1619-1637.
13. Chatziantonou VD: 2001, Telomerase: biological function and potential role in cancer management. Pathol Oncol Res 7:161-170.
14. Cong Y, Wright WE, Shay JW: 2002, Human telomerase and its regulation. Microbiol Mol Biol Rev 66:407-425.
15. Counter CM, Avilion AA, LeFeuvre CE, et al.: 1992, Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929.
16. Egenvall A, Bonnett BN, Ohagen P, et al.: 2005, Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 69:109-127.
17. Feng J, Funk WD, Wang SS, et al.: 1995, The RNA component of human telomerase. Science 269:1236-1241.
18. Funakoshi Y, Nakayama H, Uetsuka K, et al.: 2000, Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol 37:177-183.
19. Gilbertson SR, Kurzman ID, Zachrau RE, et al.: 1983, Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Vet Pathol 20:127-142.
20. Hamad NM, Banik SS, Counter CM: 2002, Mutational analysis defines a minimum level of telomerase activity required for tumorigenic growth of human cells. Oncogene 21:7121-7125.
21. Harley CB, Futcher AB, Greider CW: 1990, Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.
22. Harley CB: 1991, Telomere loss. Mitotic clock or genetic time bomb? Mutat Res 256:271-282.
23. Hiyama E, Gollahon L, Kataoka T, et al.: 1996, Telomerase activity in human breast tumours. J Natl Cancer Inst 88:116-122.
24. Hiyama E, Hiyama K, Yokoyama T, Shay JW: 2001, Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3:17-26.
25. Hiyama K, Hirai Y, Kyoizumi S, et al.: 1995, Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715.
26. Holt SE, Wright WE, Shay JW: 1997, Multiple pathways for the regulation of telomerase activity. Eur J Cancer 33:761-766.
27. Kawakami Y, Kitamoto M, Nakanishi T, et al.: 2000, Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene 19:3888-3893.
28. Kim NW, Piatyszek MA, Prowse KR, et al.: 1994, Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
29. Kim NW, Wu F: 1997, Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25:2595-2597.
30. Loveday RL, Greenman J, Drew PJ, et al.: 1999, Genetic changes associated with telomerase activity in breast cancer. Int J Cancer 84:516-520.
31. Matthews P, Jones CJ: 2001, Clinical implications of telomerase detection. Histopathology 38:485-498.
32. Misdorp W, Else RW, Hellmén E, Lipscomb TP: 1999, Histological classification of mammary tumors of the dog and cat, World Health Organization/Armed Forces Institute of Pathology, Washington, DC.
33. Moe L: 2001, Population-based incidence of mammary tumours in some dog breeds. J Reprod Fertil Suppl 57:439-443.
34. Mokbel KM, Parris CN, Ghilchik M, et al.: 2000, Telomerase activity and lymphovascular invasion in breast cancer. Eur J Surg Oncol 26:30-33.
35. Nasir L, Devlin P, Mckevitt T, et al.: 2001, Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology. Neoplasia 3:351-359.
36. Nawaz S, Hashizumi TL, Markham NE, et al.: 1997, Telomerase expression in human breast cancer with and without lymph node metastases. Am J Clin Pathol 107:542-547.
37. Owen LN: 1979, A comparative study of canine and human breast cancer. Invest Cell Pathol 2:257-275.
38. Poremba C, Heine B, Diallo R, et al.: 2002, Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 198: 181-189.
39. Poremba C, Shroyer KR, Frost M, et al.: 1999, Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions. J Clin Oncol 17:2020-2026.
40. Ramirez RD, Wright WE, Shay JW, Taylor RS: 1997, Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108:113-117.
41. Rhyu MS: 1995, Telomeres, telomerase, and immortality. J Natl Cancer Inst 87:884-894.
42. Russo V, Berardinelli P, Capacchietti G, Scapolo PA: 2003, Localization of the telomerase catalytic subunit (TERT) in pig ovarian follicles. Vet Res Commun 1:623-626.
43. Spangler EA, Rogers KS, Thomas JS, et al.: 2000, Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin. J Vet Intern Med 14:146-150.
44. Sugino T, Yoshida K, Bolodeoku J, et al.: 1996, Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 69:301-306.
45. Taylor RS, Ramirez RD, Ogoshi M, et al.: 1996, Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106:759-765.
46. Wada H, Enomoto T, Yoshino K, et al.: 2000, Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasia. Am J Clin Pathol 114:371-379.
47. Wei YM, Ou YX, Bai H, et al.: 2001, Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines. Acta Pharmacol Sin 22:725-730.
48. Wright WE, Piatyszek MA, Rainey WE, et al.: 1996, Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179.
49. Wright WE, Shay JW, Piatyszek MA: 1995, Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23:3794-3795.
50. Yano Y, Yoshida K, Osaki A, et al.: 2002, Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues. Anticancer Res 22:4101-4108.
51. Yazawa M, Okuda M, Setoguchi A, et al.: 1999, Measurement of telomerase activity in dog tumors. J Vet Med Sci 61:1125-1129.
52. Yazawa M, Okuda M, Setoguchi A, et al.: 2001, Telomere length and telomerase activity in canine mammary gland tumors. Am J Vet Res 62:1539-1543.
53. Yokoyama Y, Takahashi Y, Shinohara A, et al.: 1998, Telomerase activity is found in the epithelial cells but not in the stromal cells in human endometrial cell culture. Mol Hum Reprod 4:985-989.